NCT05881993View on ClinicalTrials.gov

Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

May 22, 2024

Study Completion Date

May 22, 2024

Conditions

Healthy Volunteer Study

Interventions

DRUG

CBP-4888

siRNA therapeutic

OTHER

Placebo

Normal Saline

Trial Locations (1)

78217

Comanche Biopharma Clinical Research Site #1, San Antonio

Sponsors

Lead Sponsor

Comanche Biopharma

All Listed Sponsors

lead

Comanche Biopharma

INDUSTRY